Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer

被引：0
|
作者：
Yufan Wang
Alexandra L McCarthy
Haitham Tuffaha
机构：
[1] The University of Queensland,School of Nursing, Midwifery and Social Work
[2] The University of Queensland,Centre for the Business and Economics of Health
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
endometrial cancer; exercise; cardiovascular disease; economic evaluation; cost-effectiveness analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer
    Wang, Yufan
    McCarthy, Alexandra
    Tuffaha, Haitham
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 60 - 60
  • [2] Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer
    Wang, Yufan
    McCarthy, Alexandra L.
    Tuffaha, Haitham
    SUPPORTIVE CARE IN CANCER, 2023, 31 (07)
  • [3] Lymphadenectomy in apparent early-stage endometrial cancer - Clinical utility and cost effectiveness
    Rodolakis, A.
    Thomakos, N.
    Vlachos, G.
    Haidopoulos, D.
    Sarris, K.
    Sotiropoulou, M.
    Papaspyrou, I.
    Antsaklis, A.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S150 - S150
  • [4] COST-UTILITY ANALYSIS OF EXERCISE FOR THE PREVENTION OF CANCER
    O'Day, K.
    Campbell, D. J.
    VALUE IN HEALTH, 2016, 19 (07) : A740 - A740
  • [5] Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
    Anne Julienne Genuino
    Usa Chaikledkaew
    Anna Melissa Guerrero
    Thanyanan Reungwetwattana
    Ammarin Thakkinstian
    BMC Health Services Research, 19
  • [6] Cost-Utility Analysis of Open Radical Hysterectomy Compared to Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
    Michaan, Nadav
    Leshno, Moshe
    Fire, Gil
    Safra, Tamar
    Rosenberg, Michal
    Peleg-Hasson, Shira
    Grisaru, Dan
    Laskov, Ido
    CANCERS, 2023, 15 (17)
  • [7] Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
    Genuino, Anne Julienne
    Chaikledkaew, Usa
    Guerrero, Anna Melissa
    Reungwetwattana, Thanyanan
    Thakkinstian, Ammarin
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (01)
  • [8] COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL
    Ferreira, V. L.
    Riveros, B.
    Leonart, L.
    Pedroso, M. L. A.
    Nita, M. E.
    Pontarolo, R.
    VALUE IN HEALTH, 2020, 23 : S174 - S174
  • [9] COST-UTILITY ANALYSIS OF TREATMENTS FOR STAGE IB CERVICAL CANCER
    Katanyoo, K.
    Praditsitthikorn, N.
    Tangjitgamol, S.
    Manusirivithaya, S.
    Supawattanabodee, B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [10] Cost-utility analysis of treatments for stage IB cervical cancer
    Katanyoo, Kanyarat
    Praditsitthikorn, Naiyana
    Tangjitgamol, Siriwan
    Manusirivithaya, Sumonmal
    Supawattanabodee, Busaba
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2014, 25 (02) : 97 - 104
12345